Bidirectional regulation of manganese superoxide dismutase (MnSOD) on the radiosensitivity of esophageal cancer cells

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 7, 2012, Pages 3015-3023

  Sun, Guo Gui ^a   Hu, Wan Ning ^a   Wang, Ya Di ^b   Yang, Cong Rong ^c   Lu, Yi Fang ^d  

^a Department of Chemoradiotherapy   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c HEBEI MEDICAL UNIVERSITY   (China)

^d Tangshan Worker's Hospital   (China)

Author keywords

Esophageal carcinoma; Manganese superoxide dismutase; Nitric oxide; Reactive oxygen species

Indexed keywords

EID: 84873583028     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.7.3015     Document Type: Article

References (39)

1. Biaglow JE, Mitchell J, Held K (1992). The importance of peroxide and superoxide in the X-ray response. Int J Radiat Oncol Biol Phys, 22, 665-9.
2. Borrelli A, Schiattarella A, Mancini R (2009). A recombinant MnSOD is radioprotective for normal cells and radiosensitizing for tumor cells. Free Radic Biol Med, 46, 110-6.
3. Bradford MM (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry, 72, 248-54.
4. Church SL, Grant JW, Ridnour LA (1993). Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells. Proc Natl Acad Sci USA, 90, 3113-7.
5. Enzinger PC, Mayer RJ (2003). Esophageal cancer. N Engl J Med, 349, 2241-52.
6. Epperly MW, Gretton JE, Sikora CA (2003). Mitochondrial localization of superoxide dismutase is required for decreasing radiation-induced cellular damage. Radiat Res, 160, 568-78.
7. Janssens MY, Verovski VN, Berge V. D. DL, et al (1999). Radiosensitization of hypoxic tumour cells by S-nitroso-Nacetylpenicillamine implicates a bioreductive mechanism of nitric oxide generation. Br J Cancer, 79, 1085-9.
8. Komatsu M, Kuroda M, Wang Y (2005). Manganese superoxide dismutase overexpression changes plating efficiency bidirectionally according to change in redox for SaOS2 human osteosarcoma cell line. Int J Oncol, 26, 853-62.
9. Lau AT, Chiu JF (2006). Proteomic and biochemical analyses of in vitro carcinogen-induced lung cell transformation: synergism between arsenic and benzo[a] pyrene. Proteomics, 6, 1619-30.
10. Lau AT, He QY, Chiu JF (2004). A proteome analysis of the arsenite response in cultured lung cells: evidence for in vitro oxidative stress-induced apoptosis. Biochem J, 382, 641-50.
11. Lau AT, Wang Y, Chiu JF (2008). Reactive oxygen species: current knowledge and applications in cancer research and therapeutic. J Cell Biochem, 104, 657-67.
12. Lindsell CJ, Griffin MJ (1999). Thermal thresholds, vibrotactile thresholds and finger systolic blood pressures in dockyard workers exposed to hand-transmitted vibration. Int Arch Occup Environ Health, 72, 377-86.
13. Lin W, Song JD, Lin JY (2001). Nitric oxide effect of proliferation of stomach cancer cell line BGC-823. Chin J Cancer, 20, 1043-8.
14. Li Z, Shi K, Guan L, (2010). ROS leads to MnSOD upregulation through ERK2 translocation and p53 activation in seleniteinduced apoptosis of NB4 cells. FEBS Lett, 584, 2291-7.
15. Nathan C (1992). Nitric oxide as a secretory product of mammalian cells. FASEB J, 6, 3051-64.
16. Nishihira T, Kasai M, Mori S (1979). Characteristics of two cell lines (TE-1 and TE-2) derived from human squamous cell carcinoma of the esophagus. Gann, 70, 575-84.
17. Niu Y, Wang H, Wiktor-Brown D (2010). Irradiated esophageal cells are protected from radiation-induced recombination by MnSOD gene therapy. Radiat Res, 173, 453-61.
18. Orrenius S, Gogvadze V, Zhivotovsky B (2007). Mitochondrial oxidative stress: implications for cell death. Annu Rev Pharmacol Toxicol, 47, 143-83.
19. Ott M, Gogvadze V, Orrenius S, Zhivotovsky B (2007). Mitochondria, oxidative stress and cell death. Apoptosis, 12, 913-22.
20. Ough M, Lewis A, Zhang Y (2004). Inhibition of cell growth by overexpression of manganese superoxide dismutase (MnSOD) in human pancreatic carcinoma. Free Radic Res, 38, 1223-33.
21. Pavord SR, Murphy PT, Mitchell VE (1996). POEMS syndrome and Waldenstrom's macroglobulinaemia. J Clin Pathol, 49, 181-2.
22. Qu Y, Zhang H, Zhao S, et al (2010). The effect on radioresistance of manganese superoxide dismutase in nasopharyngeal carcinoma. Oncol Rep, 23, 1005-11.
23. Qu Y, Zhao S, Hong J, et al (2010). Radiosensitive gene therapy through imRNA expression for silencing manganese superoxide dismutase. J Cancer Res Clin Oncol, 136, 953-9.
24. Ressel L, Poli A (2010). Simultaneous double labelling of routinely processed paraffin tissue sections using combined immunoperoxidase, immunofluorescence, and digital image editing. Res Vet Sci, 88, 122-6.
25. Sang JR, Cheng YC, Shao GB (2010). Effect of nitric oxide on the proliferation of AGC gastric cancer cells. Chin J Cancer, 29, 166-70.
26. Soini Y, Vakkala M, Kahlos K, et al (2001). MnSOD expression is less frequent in tumour cells of invasive breast carcinomas than in in situ carcinomas or non-neoplastic breast epithelial cells. J Pathol, 195, 156-62.
27. Sun GG, Wang YD, Chen LQ, et al (2011). Novel cancer suppressor gene for esophageal cancer: manganese superoxide dismutase. Dis esophagus, 24, 346-53.
28. Urano M, Kuroda M, Reynolds R (1995). Expression of manganese superoxide dismutase reduces tumor control radiation dose: gene-radiotherapy. Cancer Res, 55, 2490-3.
29. Wang MC, Guo MF, Zhao GQ (2006). Research on mRNA expression level of MnSOD gene in prostate cancer and benign prostatic hyperplasia tissue. Chin J Gerontology, 26, 164-5.
30. Wang Y, Kuroda M, Gao XS, et al (2005). Hydrogen peroxide overload increases adriamycin-induced apoptosis of SaOS(2) FM, a manganese superoxide dismutase-overexpressing human osteosarcoma cell line. Int J Oncol, 26, 1291-300.
31. Weiss L, Stern S, Reich S, et al (1993). Effect of recombinant human manganese superoxide dismutase on radiosensitivity of murine B cell leukemia (BCL1) cells. Leuk Lymphoma, 10, 477-81.
32. Weydert CJ, Waugh TA, Ritchie JM (2006). Overexpression of manganese or copper-zinc superoxide dismutase inhibits breast cancer growth. Free Radic Biol Med, 41, 226-37.
33. Wispe JR, Clark JC, Burhans MS, (1989). Synthesis and processing of the precursor for human mangano-superoxide dismutase. Biochim Biophys Acta, 994, 30-6.
34. Yan T, Oberley LW, Zhong W, et al (1996). Manganesecontaining superoxide dismutase overexpression causes phenotypic reversion in SV40-transformed human lung fibroblasts. Cancer Res, 56, 2864-71.
35. Zejnilovic J, Akev N, Yilmaz H, et al (2009). Association between manganese superoxide dismutase polymorphism and risk of lung cancer. Cancer Genet Cytogenet, 189, 1-4.
36. Zhang X, Epperly MW, Kay MA (2008). Radioprotection in vitro and in vivo by minicircle plasmid carrying the human manganese superoxide dismutase transgene. Hum Gene Ther, 19, 820-6.
37. Zhang Y, Smith BJ, Oberley LW (2006). Enzymatic activity is necessary for the tumor-suppressive effects of MnSOD. Antioxid Redox Signal, 8, 1283-93.
38. Zhang Y, Smith BJ, Oberley LW (2006). Enzymatic activity is necessary for the tumor-suppressive effects of MnSOD. Antioxid Redox Signal, 8, 1283-93.
39. Zhong W, Oberley LW, Oberley TD, et al (1997). Suppression of the malignant phenotype of human glioma cells by overexpression of manganese superoxide dismutase. Oncogene, 14, 481-90.